End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.66 CNY | +4.89% | +4.49% | -16.38% |
26/04 | DR Corporation Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
26/04 | DR Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's profit outlook over the next few years is a strong asset.
- The group's high margin levels account for strong profits.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- The company benefits from high valuations in earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Apparel & Accessories
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-16.38% | 1.3B | - | ||
+12.05% | 83.42B | A- | ||
-1.93% | 38.16B | C | ||
-5.16% | 13.93B | B+ | ||
+16.37% | 12.8B | A- | ||
+12.26% | 4.19B | - | ||
+14.89% | 2.46B | - | ||
+7.31% | 2.43B | D+ | ||
-0.47% | 1.5B | - | ||
-12.39% | 1.13B | D |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 301177 Stock
- Ratings DR Corporation Limited